10zyme are developing an innovative diagnostic technology that will empower women to effectively control their cervical health.

Providing a ‘self-test’ with instant results will increase cervical screening participation, whilst reducing strain on vital healthcare resources.

Our accessible, life-saving, cancer prevention solution will reduce the burden of health inequality in cervical cancer whilst ensuring the World Health Organization (WHO) initiative to eliminate cervical cancer globally within the next decade.